Application of Mito-Priming to Generate BCL-2 Addicted Cells.


Journal

Methods in molecular biology (Clifton, N.J.)
ISSN: 1940-6029
Titre abrégé: Methods Mol Biol
Pays: United States
ID NLM: 9214969

Informations de publication

Date de publication:
2019
Historique:
entrez: 12 12 2018
pubmed: 12 12 2018
medline: 1 6 2019
Statut: ppublish

Résumé

The majority of apoptotic stimuli trigger cell death through the mitochondrial pathway of apoptosis. Invariably, mitochondrial apoptosis requires engagement of mitochondrial outer membrane permeabilization or MOMP to initiate cell death. We have developed a new method, called mito-priming, that allows for rapid and synchronous induction of mitochondrial apoptosis in an on-target manner. Mito-priming uses coexpression of pro- and antiapoptotic Bcl-2 proteins to render cells sensitive to the addition of Bcl-2 targeting BH3-mimetic drugs. This chapter describes how to design mito-priming constructs and apply them to generate mito-primed lines. Second, we describe how to validate cell death sensitivity of mito-primed lines using different methods. Finally, we describe how to generate MOMP-resistant cell lines, using CRISPR-Cas9 mediated deletion of BAX and BAK. Facilitating the investigation of mitochondrial apoptosis, mito-priming provides a clean, robust way to induce mitochondrial apoptosis both in vitro and in vivo.

Identifiants

pubmed: 30535997
doi: 10.1007/978-1-4939-8861-7_3
doi:

Substances chimiques

BCL2 protein, human 0
Proto-Oncogene Proteins c-bcl-2 0
bcl-X Protein 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

45-60

Subventions

Organisme : Cancer Research UK
ID : C40872/A20145
Pays : United Kingdom

Auteurs

Jonathan Lopez (J)

University of Lyon, Cancer Research Centre of Lyon (CRCL), UMR INSERM 1052 CNRS 5286, Léon Bérard Centre, Lyon, France. jonathan.lopez@univ-lyon1.fr.
Department of Biochemistry and Molecular Biology, Hospices Civils de Lyon, Lyon Sud University Hospital, Pierre-Bénite, France. jonathan.lopez@univ-lyon1.fr.

Stephen W G Tait (SWG)

Cancer Research UK Beatson Institute, Glasgow, UK. stephen.tait@glasgow.ac.uk.
Institute of Cancer Sciences, University of Glasgow, Glasgow, UK. stephen.tait@glasgow.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH